HOME >> BIOLOGY >> NEWS
Experimental 'gene switch' increases lifespan with no ill effects

By experimentally switching genes off or on at specific stages in an animal's lifecycle, UCSF scientists have discovered that vigor and lifespan can be significantly extended with no side effects. Many researchers believe that increasing lifespan will dampen reproduction. But the new study of the tiny roundworm commonly known as C. elegans shows that silencing a key gene only in adulthood increases longevity with no effect on reproduction.

The focus of the research is a set of genes that control a hormonal pathway. Since the same or a similar pathway is found in many organisms including humans, the results offer the tantalizing prospect of safely and effectively extending the human lifespan as well.

The research is published in the October 25 issue of the journal SCIENCE.

Many experiments in different organisms have supported the evolutionary principle that everything comes at a price that tweaking hormone levels to boost lifespan will inevitably cause abnormal reproduction. But in the new study, UCSF scientists report for the first time that the hormonal pathways controlling reproduction and longevity act independently and can be decoupled.

Typically, to study a gene's effect, researchers knock out the gene's activity permanently. But the scientists were able to use a new technique to turn genes off at different times and thereby learn that the genes had different effects at different stages in the life of the worm. They were also able to turn the "off" genes "on" again to further probe the timing of their influence.

The UCSF scientists studied a now well-known gene called daf-2. In previously research they showed that partially disabling the gene doubles the worm's lifespan. The gene encodes a receptor for insulin as well as for a hormone called insulin-like growth factor. The same or related hormone pathways have since been shown to affect lifespan in fruit flies and mice, and therefore are likely to control lifespan in h
'"/>

Contact: Wallace Ravven
wravven@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
24-Oct-2002


Page: 1 2 3 4

Related biology news :

1. Experimental drug shown to block mutant protein causing blood disease
2. Experimental smallpox DNA vaccine protects primates from lethal monkeypox
3. Experimental smallpox vaccine protects against monkeypox in nonhuman primates
4. Experimental Biology 2004 - Translating the Genome
5. Experimental Biology 2004 meets in Washington, D.C. April 17-21
6. Experimental hantavirus vaccine elicits strong antibody response in primates
7. Experimental cancer drugs may halt events that lead to cardiac hypertrophy and heart failure
8. Experimental Biology 2003 meets in San Diego April 11-15
9. Experimental Biology 2003 meets in San Diego April 11-15
10. Experimental therapy stops allergic reactions in mice
11. APS awards 44 minority travel fellowships to the Experimental Biology 2002 meeting

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/4/2019)... TORONTO (PRWEB) , ... June 04, 2019 , ... ... automate the search for salient features of seizure risk signals, usually based on ... neurologist-driven EEG interpretation remains the only acceptable diagnostic methodology due to the complexity ...
(Date:6/1/2019)... ... May 31, 2019 , ... ... & Rosati recently invested in BioFactura’s $6M Series B Financing Round. , ... value-added institutional investors who bring significant financial and business resources to bear as ...
(Date:5/31/2019)... ... 2019 , ... Join Julie Peacock, Vice President of Product ... June 19, 2019 at 1pm EDT where she will demonstrate how role-based data ... contract research organizations (CROs) can improve collaboration, auditing, document tracking and reporting. , ...
Breaking Biology News(10 mins):
(Date:5/31/2019)... California (PRWEB) , ... May ... ... of our patent applications from the USPTO providing proprietary interest to our ... METHOD FOR SLEEP DISORDER DIAGNOSIS AND TREATMENT… extends Somnology’s IP rights including ...
(Date:5/31/2019)... ... May 30, 2019 , ... A study released today ... system for the sustained release of human placental stem cell (HPSC)-derived conditioned medium ... to deliver CM into the injured kidney, where it helped restore function and ...
(Date:5/15/2019)... (PRWEB) , ... May 15, 2019 , ... Milton Hershey ... in recognition for his work within the biomedical industry, where he is changing lives ... medical devices. , “William Harding epitomizes the vision of our founders – Milton ...
(Date:5/14/2019)... Calif. (PRWEB) , ... May 14, 2019 , ... ... office expansion, effectively doubling its space from 2,500 to 5,000 square feet. , ... Early Gender DNA tests ,” says Gateway Genomics CEO, Chris Jacob. “The SneakPeek At-Home ...
Breaking Biology Technology:
Cached News: